Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Aravinda de Silva"'
Autor:
Sandra Bos, Aaron L. Graber, Jaime A. Cardona-Ospina, Elias M. Duarte, Jose Victor Zambrana, Jorge A. Ruíz Salinas, Reinaldo Mercado-Hernandez, Tulika Singh, Leah C. Katzelnick, Aravinda de Silva, Guillermina Kuan, Angel Balmaseda, Eva Harris
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-13 (2024)
Abstract Dengue viruses (DENV1–4) are the most prevalent arboviruses in humans and a major public health concern. Understanding immune mechanisms that modulate DENV infection outcome is critical for vaccine development. Neutralizing antibodies (nAb
Externí odkaz:
https://doaj.org/article/f88d6ae0f5f54903a2beaf3fc606c18e
Autor:
Erick X. Pérez-Guzmán, Petraleigh Pantoja, Crisanta Serrano-Collazo, Mariah A. Hassert, Alexandra Ortiz-Rosa, Idia V. Rodríguez, Luis Giavedoni, Vida Hodara, Laura Parodi, Lorna Cruz, Teresa Arana, Laura J. White, Melween I. Martínez, Daniela Weiskopf, James D. Brien, Aravinda de Silva, Amelia K. Pinto, Carlos A. Sariol
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-14 (2019)
Here, the authors show that the time elapsed between Zika infection and subsequent dengue virus infection affects the magnitude and durability of the antibody and cell-mediated immune responses against dengue virus, but not viremia. This research in
Externí odkaz:
https://doaj.org/article/df47fefed1b64aed9ca8592422e25d1d
Publikováno v:
Bio-Protocol, Vol 11, Iss 10 (2021)
The recombinant receptor-binding domain (RBD) of the viral spike protein from SARS-CoV-1 and 2 are reliable antigens for detecting viral-specific antibodies in humans. We and others have shown that the levels of RBD-binding antibodies and SARS-CoV-2
Externí odkaz:
https://doaj.org/article/51b5a7dea1c743cfb947e38b5b295b7d
Autor:
Crisanta Serrano-Collazo, Erick X Pérez-Guzmán, Petraleigh Pantoja, Mariah A Hassert, Idia V Rodríguez, Luis Giavedoni, Vida Hodara, Laura Parodi, Lorna Cruz, Teresa Arana, Melween I Martínez, Laura White, James D Brien, Aravinda de Silva, Amelia K Pinto, Carlos A Sariol
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 14, Iss 5, p e0008285 (2020)
Little is known about the contribution of virus-specific and cross-reacting antibodies (Abs) or the cellular immune response generated by a primary dengue (DENV) infection on the course of a secondary zika (ZIKV) infection in vivo. Here we show that
Externí odkaz:
https://doaj.org/article/e3652dd777f541288f09136180a0c351
Autor:
Petraleigh Pantoja, Erick X. Pérez-Guzmán, Idia V. Rodríguez, Laura J. White, Olga González, Crisanta Serrano, Luis Giavedoni, Vida Hodara, Lorna Cruz, Teresa Arana, Melween I. Martínez, Mariah A. Hassert, James D. Brien, Amelia K. Pinto, Aravinda de Silva, Carlos A. Sariol
Publikováno v:
Nature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
Antibodies against dengue virus (DENV) can increase Zika virus (ZIKV) infectionin vitro, but their role in vivoremains largely unknown. Here, the authors show that pre-existing immunity from a 2.8 years earlier DENV infection does not affect ZIKV pat
Externí odkaz:
https://doaj.org/article/0da3c5399a8a4c87b377fe65a7d69926
Autor:
Guntur Fibriansah, Joanne L Tan, Scott A Smith, Adamberage R de Alwis, Thiam‐Seng Ng, Victor A Kostyuchenko, Kristie D Ibarra, Jiaqi Wang, Eva Harris, Aravinda de Silva, James E Crowe, Shee‐Mei Lok
Publikováno v:
EMBO Molecular Medicine, Vol 6, Iss 3, Pp 358-371 (2014)
Abstract Dengue virus (DENV), which consists of four serotypes (DENV1‐4), infects over 400 million people annually. Previous studies have indicated most human monoclonal antibodies (HMAbs) from dengue patients are cross‐reactive and poorly neutra
Externí odkaz:
https://doaj.org/article/5a2bbed09b4a44cd9ed0e1bdfbeffee2
Autor:
Megan E. Reller, Champika Bodinayake, Ajith Nagahawatte, Vasantha Devasiri, Wasantha Kodikara-Arachichi, John J. Strouse, Anne Broadwater, Truls Østbye, Aravinda de Silva, Christopher W. Woods
Publikováno v:
Emerging Infectious Diseases, Vol 18, Iss 2, Pp 256-263 (2012)
Dengue virus (DENV), a globally emerging cause of undifferentiated fever, has been documented in the heavily urbanized western coast of Sri Lanka since the 1960s. New areas of Sri Lanka are now being affected, and the reported number and severity of
Externí odkaz:
https://doaj.org/article/d34c8335b0f34d79b7efa7a71be3ebd1
Autor:
Shailendra Mani, Lav Tripathi, Rajendra Raut, Poornima Tyagi, Upasana Arora, Tarani Barman, Ruchi Sood, Alka Galav, Wahala Wahala, Aravinda de Silva, Sathyamangalam Swaminathan, Navin Khanna
Publikováno v:
PLoS ONE, Vol 8, Iss 5, p e64595 (2013)
Dengue is a mosquito-borne viral disease with a global prevalence. It is caused by four closely-related dengue viruses (DENVs 1-4). A dengue vaccine that can protect against all four viruses is an unmet public health need. Live attenuated vaccine dev
Externí odkaz:
https://doaj.org/article/02a210b024a847a7b5bb68d96eb5272e
Autor:
Aravinda, de Silva, Laura, White
Publikováno v:
J Infect Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d5af3a6ae372a47301eb249bb6fbe9b
https://doi.org/10.1093/infdis/jiac424
https://doi.org/10.1093/infdis/jiac424
Autor:
Aravinda de Silva
Publikováno v:
Clin Infect Dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd514039ba3e63033218ea0152d9fff
https://doi.org/10.1093/cid/ciac690
https://doi.org/10.1093/cid/ciac690